FierceBiotech

Dexcom hit by FDA Class I recall for its continuous glucose monitoring system app

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous glucose monitoring system app, leading the FDA to issue its most serious recall notice. A “software defect in ...
Business Wire

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 ...
pharmaphorum

Lilly doubles down on Dexcom tech for connected insulin devices

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...
Hosted on MSN

DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs

DexCom Inc. DXCM and Abbott Laboratories ABT are likely to launch their first over-the-counter (OTC) continuous glucose monitors (CGMs) in the coming months of 2024. Dexcom’s Stelo and Abbott’s Lingo ...